Jennifer Donnell

Antibody–Drug Conjugate Sacituzumab Govitecan Drives Efficient Tissue Penetration and Rapid Intracellular Drug Release

Anna Kopp, Scott Hofsess, Thomas M. Cardillo et al. · Molecular Cancer Therapeutics · 2022 · 91 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Selective and Concentrated Accretion of SN-38 with a CEACAM5-Targeting Antibody–Drug Conjugate (ADC), Labetuzumab Govitecan (IMMU-130)

Robert M. Sharkey, Serengulam V. Govindan, Thomas M. Cardillo et al. · Molecular Cancer Therapeutics · 2017 · 40 citations

Pharmacy, Oncology, Pharmacology +17

Development of a series of novel o-phenylenediamine-based indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors

David Williams, Jay A. Markwalder, Aaron Balog et al. · Bioorganic & Medicinal Chemistry Letters · 2018 · 17 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9

Improving Intracellular Delivery of an Antibody–Drug Conjugate Targeting Carcinoembryonic Antigen Increases Efficacy at Clinically Relevant Doses <i>In Vivo</i>

Ian Nessler, Baron Rubahamya, Anna Kopp et al. · Molecular Cancer Therapeutics · 2023 · 15 citations · Full text

Pharmacy, Molecular Pharmaceutics, Oncology +17